Age: 72.0
Sex: M
Vaccine: COVID19, FLUX, RSV
Symptoms: Pain, Productive cough, Rhinorrhoea
Clinical narrative: Runny nose; Congested; Fatigued; Weak; Coughing up mucus; Weakened voice; pain; Deep pressure in his lungs and chest; Deep pressure in his lungs and chest; This is a spontaneous report received from a Consumer or other non HCP.  A 72-year-old male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 27Sep2023 as dose number unknown, single (Lot number: H09835) at the age of 72 years, in right arm for immunisation; BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 27Sep2023 as dose 1, single (Batch/Lot number: unknown) at the age of 72 years, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 27Sep2023 as dose number unknown, single), in right arm for immunisation. The patient's relevant medical history included: "Muscle spasms" (unspecified if ongoing); "Sleep" (unspecified if ongoing); "Cognition" (unspecified if ongoing); "Immunization" (unspecified if ongoing), notes: Pfizer Vaccine. Concomitant medication(s) included: ARICEPT taken for cognitive disorder; LYRICA taken for muscle spasms; LUNESTA taken for sleep disorder; TRAZODONE taken for sleep disorder. The patient also took other concomitant therapy. The following information was reported: CHEST DISCOMFORT (non-serious), LUNG DISORDER (non-serious) all with onset 02Nov2023, outcome "not recovered" and all described as "Deep pressure in his lungs and chest"; DYSPHONIA (non-serious) with onset 02Nov2023, outcome "not recovered", described as "Weakened voice"; PAIN (non-serious) with onset 02Nov2023, outcome "not recovered"; RHINORRHOEA (non-serious), outcome "not recovered", described as "Runny nose"; NASAL CONGESTION (non-serious), outcome "not recovered", described as "Congested"; FATIGUE (non-serious), outcome "not recovered", described as "Fatigued"; ASTHENIA (non-serious), outcome "not recovered", described as "Weak"; PRODUCTIVE COUGH (non-serious), outcome "not recovered", described as "Coughing up mucus". The events "deep pressure in his lungs and chest", "coughing up mucus" and "pain" required emergency room visit. Therapeutic measures were taken as a result of chest discomfort, lung disorder, rhinorrhoea, nasal congestion, fatigue, asthenia, productive cough, dysphonia. Additional information: Reporter and Consumer both were on the call. This is a call for my father. He received the RSV Pfizer vaccine (Abrysvo) at (Name withheld) with the (withheld) in September like a 3rd week of September of this year and he is really having a long haul side effects. It started with some coughing and deep pressure in his lungs and chest and as long and he went to an emergency room. He did not have a fever. So, they did not really address it. He's (consumer) done over the counter medications (Unspecified medications) and he did try antibiotics (Unspecified medications) but the symptoms are not going away and we just wanted to call in and see if we 'get hold of' a couple of other people that are elderly that are kind of experiencing same thing and so we wanted to see if you guys are getting feedback on your studies, if there are any reports or any additional (sentence incomplete). " When probed if the consumer was still experiencing the event (deep pressure in lungs and chest) Reporter stated, "He is experiencing different problem. He's like runny nose, congested, extremely fatigued, very weak, he is coughing up mucus and his voice like he has a weakened voice. He is just being persistent, he has tried everything over the counter. He has antibiotics (Unspecified Medications) and he is still having these." Treatment: Reporter stated, "He said sinus 'range'? No, treatment was given with the ER, they just because he did not have a fever, they did not give antibiotics. So, he just had, was given like Aspirin (81mg, in the morning). like nasal clearing and things like that, cough depressant, stuff like that. Aspirin, nasal spray." When probed for the indication of nasal spray, reporter stated, "Congestion also he took Tylenol (treatment)." When probed for the route of administration, formulation and frequency of the Tylenol, Reporter stated, "500mg for pain." Vaccination facility is a grocery store. About 11 o'clock (unspecified time). Lab. work: Reporter stated, "No, last two weeks." The information on the batch/lot number for rsv vaccine prot.subunit pref 2v , BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.